Lawrence Young

21 - 30 out of 149Page size: 10
Sort by: Title

Publications

  1. Published

    CD40 ligand induced cytotoxicity in carcinoma cells is enhanced by inhibition of metalloproteinase cleavage and delivery via a conditionally-replicating adenovirus

    Peter Searle, Lawrence Young & Daniel Palmer, 1 Mar 2010, In: Molecular Cancer. 9, p. 52 1 p.

    Research output: Contribution to journal › Article

  2. Published

    CD40 ligand-induced carcinoma cell death: a balance between activation of TNFR-associated factor (TRAF) 3-dependent death signals and suppression of TRAF6-dependent survival signals.

    Lawrence Young & Daniel Palmer, 15 Jan 2010, In: Journal of Immunology. 184, 2, p. 1111-20 10 p.

    Research output: Contribution to journal › Article

  3. Published

    CD40 mediated human cholangiocyte apoptosis requires JAK2 dependent activation of STAT3 in addition to activation of JNK1/2 and ERK1/2

    Jalal Ahmed-Choudhury, Kevin Williams, Lawrence Young, David Adams & Simon Afford, Apr 2006, In: Cellular Signalling. 18, 4, p. 456-68 13 p.

    Research output: Contribution to journal › Article › peer-review

  4. Published

    Cancer gene therapy: Clinical trials

    Daniel Palmer, Lawrence Young & Vivien Mautner, 1 Feb 2006, In: Trends in Biotechnology. 24, p. 76-82 7 p.

    Research output: Contribution to journal › Review article

  5. Published

    Carbonic anhydrase IX, a marker of hypoxia: Correlation with clinical outcome in transitional cell carcinoma of the bladder

    Syed Hussain, Daniel Palmer, Louise Hiller, Paul Murray, Lawrence Young & Nicholas James, 1 Jan 2004, In: Oncology reports. 11, p. 1005-1010 6 p.

    Research output: Contribution to journal › Article

  6. Published

    Cigarette smoking is an independent risk factor for cervical intraepithelial neoplasia in young women: A longitudinal study

    Stuart Collins, Lawrence Young, 9 Oct 2009, In: European Journal of Cancer.

    Research output: Contribution to journal › Article

  7. Published

    Combined adenovirus-mediated nitroreductase gene delivery and CB1954 treatment: A well-tolerated therapy for established solid tumours

    Peter Searle, Lawrence Young, David Kerr, 1 Feb 2001, In: Molecular Therapy. 3, 2, p. 233-240 8 p.

    Research output: Contribution to journal › Article

  8. Published

    Combining gene and immunotherapy for prostate cancer

    Vivien Mautner, Peter Searle, Lawrence Young & Nicholas James, 1 Jan 2008, In: Prostate Cancer and Prostatic Diseases. 11, 2, p. 187-93 7 p.

    Research output: Contribution to journal › Article

  9. Published

    Constitutive activation of phosphatidyl-inositide 3 kinase contributes to the survival of Hodgkin's lymphoma cells through a mechanism involving AKT kinase and mTOR

    Amanda Dutton, Christopher Dawson, Lawrence Young & Paul Murray, 1 Mar 2005, In: Journal of Pathology. 205, p. 498-506 9 p.

    Research output: Contribution to journal › Article

  10. Published

    Constitutive activation of the CD40 pathway promotes cell transformation and neoplastic growth

    Christopher Dawson, Suzanne Stewart, John Gordon, Paul Murray, Lawrence Young & Aris Eliopoulos, 8 Aug 2005, In: Oncogene. 24, p. 7913-7923 11 p.

    Research output: Contribution to journal › Article

Previous 1 2 3 4 5 6 7 8 ...15 Next